Special Issue "Advances in Cervical Cancer: From Pathogenesis to Therapy"
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 192
Cervical cancer is the fourth leading cause of cancer-related deaths in women.
Multidisciplinary treatments such as surgery (open or minimally invasive surgery), radiotherapy, molecular-targeted drugs, and immune checkpoint inhibitors are in clinical use and at various stages of preclinical and clinical development.
MIS, in particular, is the preferred approach; however, recent data on cervical cancer surgery (LACC trial) require a thorough reassessment.
Papers focusing on histopathology examination techniques, validation of diagnostic tools, the development of innovative materials and therapies, gene therapy, and descriptions of new surgical approaches are also welcome.
Dr. Eiji Kondo
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cervical cancer
- minimally invasive surgery
- multidisciplinary treatment
- new surgical approach
- molecular-targeted drugs
- immune checkpoint inhibitors